Imidazole → 2-((Tert-butyldiphenylsilyloxy)methyl)-4-methyl-5-nitropyridine
反応式
[CH3:1][C:2]1[C:7]([N+:8]([O-:10])=[O:9])=[CH:6][N:5]=[C:4]([CH2:11][OH:12])[CH:3]=1.[C:13]([Si:17](Cl)([C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1)[C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1)([CH3:16])([CH3:15])[CH3:14].N1C=CN=C1.O>C(Cl)Cl>[Si:17]([O:12][CH2:11][C:4]1[CH:3]=[C:2]([CH3:1])[C:7]([N+:8]([O-:10])=[O:9])=[CH:6][N:5]=1)([C:13]([CH3:16])([CH3:15])[CH3:14])([C:24]1[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=1)[C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1参加物
6
反応条件
- 温度
- 25 °C
実験手順
To a solution of (4-methyl-5-nitropyridin-2-yl)methanol (1.2 g, 7.1 mmol) in 5 mL of CH2Cl2, were added tert-butylchlorodiphenylsilane (2.0 g, 7.1 mmol) and imidazole (0.049 g, 0.71 mmol) at an ambient temperature. The reaction was stirred at 25° C. for 2 hrs. The reaction was poured into H2O, extracted with ethyl acetate, and dried over MgSO4. The ethyl acetate was concentrated under vacuum and purified over SiO2 to afford the desired compound 2-((tert-butyldiphenylsilyloxy)methyl)-4-methyl-5-nitropyridine in 90% (2.6 g). 1HNMR (CDCl3, 400 MHz) δ 1.12 (s, 9H), 2.78 (s, 3H), 4.85 (s, 2H), 7.21 (s, 1H), 7.24˜7.89 (m, 10H), 9.15 (s, 1H).
後処理
- extractionextracted with ethyl acetate
- dry with materialdried over MgSO4
- concentrationThe ethyl acetate was concentrated under vacuum
- custompurified over SiO2
出典と根拠
- ORDレコード
- ord-3f01225409f84ae787ff99db1b4dc9ae
- 出典データセット
- uspto-grants-2013_01
- 特許番号
- US08362248B2
反応ノート
読み込み中…